TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive NCI plans to cut staff access to The Cancer Letter; insiders allege attempt at “thought control.” November 18, 2005
TCL Archive New CCOP RFA To Encourage Cancer Control Research; Larger But Fewer Awards Are Likely May 9, 1986
